Revvity, Inc. (RVTY) Financial Ratios
30 years of historical data (1996–2025) · Healthcare · Medical - Diagnostics & Research
EV/EBITDA
↑
20.91
+10% vs avg
5yr avg: 18.96
30Y Low6.3·High24.2
P/FCF
↑
22.00
↓-93% vs avg
5yr avg: 294.41
30Y Low9.5·High109.1
P/B Ratio
↓
1.56
↓-27% vs avg
5yr avg: 2.14
30Y Low0.8·High7.3
ROE
↓
3.2%
↑-47% vs avg
5yr avg: 6.1%
30Y Low-2%·High28%
Debt/EBITDA
↑
5.34
↑+26% vs avg
5yr avg: 4.22
30Y Low0.7·High5.3
Percentile shows where the current value sits in 30-year historical distribution. Sparklines show 5-year trend.
RVTY Valuation Multiples
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
Revvity, Inc. trades at 48.1x earnings, 29% above its 5-year average of 37.3x, sitting at the 85th percentile of its historical range. Compared to the Healthcare sector median P/E of 22.1x, the stock trades at a premium of 117%. On a free-cash-flow basis, the stock trades at 22.0x P/FCF, 93% below the 5-year average of 294.4x.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $11.2B | $11.0B | $13.8B | $13.6B | $17.7B | $23.5B | $16.1B | $10.8B | $8.8B | $8.1B | $5.8B |
| Enterprise Value | $13.8B | $13.5B | $15.9B | $16.8B | $21.9B | $28.0B | $17.9B | $12.9B | $10.5B | $9.9B | $6.4B |
| P/E Ratio → | 48.08 | 46.51 | 46.47 | — | 31.15 | 24.87 | 22.09 | 47.58 | 36.69 | 71.72 | 24.62 |
| P/S Ratio | 3.91 | 3.84 | 4.99 | 4.96 | 5.35 | 6.13 | 4.25 | 3.75 | 3.15 | 3.59 | 2.72 |
| P/B Ratio | 1.56 | 1.51 | 1.79 | 1.73 | 2.40 | 3.28 | 4.31 | 3.85 | 3.39 | 3.24 | 2.67 |
| P/FCF | 22.00 | 21.55 | 25.39 | 1377.54 | 29.84 | 17.71 | 19.41 | 38.37 | 40.23 | 32.51 | 18.04 |
| P/OCF | 19.22 | 18.83 | 21.89 | 149.48 | 26.08 | 16.63 | 18.03 | 29.79 | 28.17 | 28.10 | 16.41 |
P/E links to full P/E history page with 30-year chart
RVTY EV Ratios
Enterprise-value multiples — capital-structure-neutral measures of total business value
Revvity, Inc.'s enterprise value stands at 20.9x EBITDA, 10% above its 5-year average of 19.0x. The Healthcare sector median is 14.2x, placing the stock at a 47% premium on an enterprise-value basis.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 4.74 | 5.78 | 6.11 | 6.60 | 7.32 | 4.73 | 4.47 | 3.78 | 4.39 | 3.04 |
| EV / EBITDA | 20.91 | 20.56 | 18.99 | 20.20 | 18.10 | 16.96 | 14.14 | 20.81 | 19.02 | 24.19 | 15.88 |
| EV / EBIT | 38.63 | 37.59 | 38.60 | 59.60 | 28.93 | 21.46 | 18.72 | 42.86 | 32.31 | 29.09 | 22.55 |
| EV / FCF | — | 26.66 | 29.39 | 1695.81 | 36.80 | 21.15 | 21.61 | 45.69 | 48.17 | 39.74 | 20.19 |
RVTY Profitability
Margins and return-on-capital ratios measuring operating efficiency
Revvity, Inc. earns an operating margin of 12.5%. Operating margins have compressed from 14.5% to 12.5% over the past 3 years, signaling potential cost pressures or competitive headwinds. ROE of 3.2% is modest. ROIC of 2.7% represents below-average returns on invested capital.
Margins
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 53.1% | 53.1% | 48.0% | 48.1% | 53.2% | 59.6% | 52.6% | 44.8% | 45.0% | 45.6% | 46.0% |
| Operating Margin | 12.5% | 12.5% | 14.9% | 14.5% | 23.6% | 35.0% | 27.0% | 14.1% | 13.4% | 13.5% | 14.4% |
| Net Profit Margin | 8.5% | 8.5% | 10.7% | -4.3% | 17.2% | 24.6% | 19.2% | 7.9% | 8.6% | 5.0% | 11.0% |
Return on Capital
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 3.2% | 3.2% | 3.8% | -1.6% | 7.8% | 17.3% | 22.2% | 8.4% | 9.4% | 4.9% | 11.0% |
| ROA | 2.0% | 2.0% | 2.3% | -0.9% | 3.9% | 8.2% | 10.0% | 3.6% | 4.0% | 2.2% | 5.5% |
| ROIC | 2.7% | 2.7% | 3.0% | 2.7% | 5.0% | 11.7% | 14.7% | 6.6% | 6.5% | 6.4% | 8.0% |
| ROCE | 3.2% | 3.2% | 3.4% | 3.2% | 5.9% | 13.3% | 16.9% | 7.4% | 7.2% | 6.9% | 8.4% |
RVTY Leverage & Debt
Solvency and debt-coverage ratios — lower is generally safer
Revvity, Inc. carries a Debt/EBITDA ratio of 5.3x, which is highly leveraged (66% above the sector average of 3.2x). Net debt stands at $2.6B ($3.5B total debt minus $920M cash). Interest coverage of 3.9x is adequate, though a cyclical earnings downturn could tighten the margin of safety.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.48 | 0.48 | 0.43 | 0.52 | 0.62 | 0.72 | 0.59 | 0.80 | 0.73 | 0.80 | 0.49 |
| Debt / EBITDA | 5.34 | 5.34 | 3.97 | 4.89 | 3.80 | 3.12 | 1.75 | 3.64 | 3.43 | 4.90 | 2.58 |
| Net Debt / Equity | — | 0.36 | 0.28 | 0.40 | 0.56 | 0.64 | 0.49 | 0.73 | 0.67 | 0.72 | 0.32 |
| Net Debt / EBITDA | 3.94 | 3.94 | 2.58 | 3.79 | 3.43 | 2.76 | 1.44 | 3.33 | 3.14 | 4.40 | 1.69 |
| Debt / FCF | — | 5.11 | 3.99 | 318.27 | 6.97 | 3.44 | 2.19 | 7.32 | 7.94 | 7.23 | 2.15 |
| Interest Coverage | 3.91 | 3.91 | 4.28 | 2.85 | 7.27 | 12.79 | 19.23 | 4.73 | 4.85 | 7.75 | 6.88 |
RVTY Liquidity & Efficiency
Short-term solvency ratios and asset-utilisation metrics
A current ratio of 1.68x means Revvity, Inc. can comfortably meet its short-term obligations, though there is limited excess liquidity. The current ratio has declined from 2.07x to 1.68x over the past 3 years.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.68 | 1.68 | 3.60 | 2.07 | 2.13 | 2.01 | 1.36 | 1.80 | 1.60 | 1.26 | 1.97 |
| Quick Ratio | 1.40 | 1.40 | 3.03 | 1.77 | 1.87 | 1.66 | 1.04 | 1.33 | 1.16 | 0.89 | 1.56 |
| Cash Ratio | 0.69 | 0.69 | 1.78 | 1.11 | 0.29 | 0.50 | 0.24 | 0.25 | 0.21 | 0.21 | 0.60 |
| Asset Turnover | — | 0.23 | 0.22 | 0.20 | 0.23 | 0.26 | 0.48 | 0.44 | 0.46 | 0.37 | 0.49 |
| Inventory Turnover | 3.53 | 3.53 | 3.90 | 3.34 | 3.83 | 3.63 | 3.48 | 4.46 | 4.51 | 3.49 | 4.63 |
| Days Sales Outstanding | — | 95.17 | 83.78 | 83.97 | 67.54 | 67.51 | 111.46 | 91.79 | 83.13 | 89.32 | 73.43 |
RVTY Shareholder Yields
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Revvity, Inc. returns 7.6% to shareholders annually — split between a 0.3% dividend yield and 7.3% buyback yield. The payout ratio of 13.6% is conservative, leaving significant room for dividend growth or reinvestment. The earnings yield of 2.1% (inverse of P/E) provides a useful comparison to bond yields when assessing the stock's relative attractiveness to fixed income.
Dividends
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | 0.3% | 0.3% | 0.3% | 0.3% | 0.2% | 0.1% | 0.2% | 0.3% | 0.4% | 0.4% | 0.5% |
| Payout Ratio | 13.6% | 13.6% | 11.6% | — | 6.2% | 3.4% | 4.3% | 13.6% | 13.0% | 27.2% | 13.2% |
Total Shareholder Return Metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | 2.1% | 2.1% | 2.2% | — | 3.2% | 4.0% | 4.5% | 2.1% | 2.7% | 1.4% | 4.1% |
| FCF Yield | 4.5% | 4.6% | 3.9% | 0.1% | 3.4% | 5.6% | 5.2% | 2.6% | 2.5% | 3.1% | 5.5% |
| Buyback Yield | 7.3% | 7.5% | 2.7% | 2.9% | 0.5% | 0.3% | 0.0% | 0.1% | 0.7% | 0.0% | 2.6% |
| Total Shareholder Yield | 7.6% | 7.8% | 2.9% | 3.1% | 0.7% | 0.4% | 0.2% | 0.3% | 1.0% | 0.4% | 3.2% |
| Shares Outstanding | — | $113M | $123M | $125M | $126M | $117M | $112M | $112M | $112M | $111M | $110M |
Peer Comparison
Compare RVTY with 10 similar companies in its peer group
| Company | Market Cap | P/E | EV/EBITDA | P/FCF | Gross Margin | Op Margin | ROE | ROIC | Debt/EBITDA |
|---|---|---|---|---|---|---|---|---|---|
 RVTYYou | $11B | 48.1 | 20.9 | 22.0 | 53.1% | 12.5% | 3.2% | 2.7% | 5.3 |
 WAT | $23B | 33.0 | 21.8 | 42.9 | 57.8% | 28.2% | 29.3% | 20.3% | 1.3 |
 BRKR | $9B | -381.5 | 22.9 | 201.2 | 45.9% | 6.9% | -0.4% | 4.4% | 4.5 |
 MTD | $23B | 27.1 | 20.4 | 27.3 | 57.5% | 27.8% | — | 40.0% | 1.9 |
 BIO | $8B | 10.1 | 18.1 | 20.4 | 52.0% | 10.5% | 10.8% | 2.6% | 3.2 |
 HOLX | $17B | 30.5 | 17.4 | 18.4 | 61.0% | 17.4% | 11.1% | 9.4% | 2.6 |
 TMO | $173B | 26.2 | 18.7 | 27.4 | 37.7% | 18.2% | 13.1% | 7.5% | 3.8 |
 DHR | $125B | 35.2 | 18.4 | 23.8 | 60.9% | 20.9% | 7.1% | 5.9% | 2.4 |
 A | $36B | 27.8 | 21.2 | 31.2 | 52.4% | 21.3% | 20.6% | 13.5% | 1.9 |
 QGEN | $8B | 18.1 | 11.8 | 16.8 | 61.8% | 24.9% | 11.6% | 8.6% | 2.3 |
 ILMN | $25B | 29.7 | 22.7 | 26.4 | 66.7% | 19.9% | 33.4% | 16.8% | 2.3 |
| Healthcare Median | — | 22.1 | 14.2 | 18.5 | 63.9% | -4.3% | -32.6% | -11.6% | 3.2 |
Peer selection based on competitive and market overlap. Compare multiple stocks →
Download Financial Ratios Data
Includes 30+ ratios · 30 years · Updated daily
Consensus-Based Analysis Tools
Full Stock Analysis
Deep dive into RVTY consensus models and risk factors.
View Analysis
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Check Valuation
Historical Returns
10-year return with dividends reinvested.
Calculate
DCA Calculator
See how regular investing compounds over time.
Run Numbers
Peer Comparison
Compare growth, multiples, and margins vs sector.
Compare
RVTY — Frequently Asked Questions
Quick answers to the most common questions about buying RVTY stock.
What is Revvity, Inc.'s P/E ratio?
Revvity, Inc.'s current P/E ratio is 48.1x. The historical average is 34.3x. This places it at the 85th percentile of its historical range.
What is Revvity, Inc.'s EV/EBITDA?
Revvity, Inc.'s current EV/EBITDA is 20.9x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 14.9x.
What is Revvity, Inc.'s ROE?
Revvity, Inc.'s return on equity (ROE) is 3.2%. The historical average is 8.5%.
Is RVTY stock overvalued?
Based on historical data, Revvity, Inc. is trading at a P/E of 48.1x. This is at the 85th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
What is Revvity, Inc.'s dividend yield?
Revvity, Inc.'s current dividend yield is 0.29% with a payout ratio of 13.6%.
What are Revvity, Inc.'s profit margins?
Revvity, Inc. has 53.1% gross margin and 12.5% operating margin. Operating margin between 10-20% is typical for established companies.
How much debt does Revvity, Inc. have?
Revvity, Inc.'s Debt/EBITDA ratio is 5.3x, indicating high leverage. A ratio above 4x may signal elevated financial risk.